Tag: Histotripsy
-
Zhen Xu Receives Golden Goose Award from the American Association for the Advancement of Science
This award recognizes transformative work enabled by federal funding, which was crucial to advancing the tumor-destroying soundwaves until they were ready for the clinic.
-
Histotripsy Center Celebrates Opening, with Goal of Accelerating the Future of Non-Invasive Cancer Treatment
When histotripsy received FDA clearance for the noninvasive treatment of liver tumors in October 2023, it marked a milestone more than two decades in the making for University of Michigan researchers who helped pioneer the technology.
-
Zhen Xu Honored as a 2026 Recipient of the Sony Women in Technology Award with Nature
Dr. Xu was selected for her pioneering work as a co-inventor of the field of histotripsy.
-
Zhen Xu Receives Stephen S. Attwood Excellence in Engineering Award
Prof. Xu is a trailblazer in both clinical innovation and academic leadership through her research in the discovery of histotripsy, here at U-M.
-
Researchers Are Examining Ways to Use Histotripsy to Stimulate the Immune System Against Cancer
Histotripsy can help release HER2 from cancer tumor cells.
-
Dr. Zhen Xu Receives Multiple Honors for Pioneering Work in Non-Invasive Cancer Treatment
Dr. Xu has been awarded the Li Ka-Shing Endowed Professorship in Biomedical Engineering, College of Engineering, effective December 1, 2024 through November 30, 2029.
-
Tumor-destroying soundwaves receive FDA approval for liver treatment in humans
Technique developed at the University of Michigan provides a non-invasive alternative to surgery, chemotherapy and radiation treatments for cancer.
-
Histotripsy researchers receive Distinguished University Innovator Award
Technology holds promise to permit patients with diseased tissue to obtain treatment with less discomfort and faster recovery times than traditional surgery.
-
Tumors partially destroyed with sound don’t come back, in rats
Technique pioneered at the University of Michigan could improve outcomes for cancer and neurological conditions.
-
Ultrasound Technology Developed at U-M Now in Clinical Trials for Liver Cancer
Trial will evaluate the safety and efficacy of histrotripsy against liver tumors at eight U.S. sites.